Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “COVID 19 Associated Coagulopathy”

16 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 16 of 16 results

Large-scale testing (Phase 3)Ended earlyNCT04345848
What this trial is testing

Preventing COVID-19 Complications With Low- and High-dose Anticoagulation

Who this might be right for
COVIDSars-CoV2
University Hospital, Geneva 160
Not applicableStudy completedNCT05679414
What this trial is testing

Prevalence of Thrombophilic Gene Polymorphism (MTHFR C677T) in COVID-19patients

Who this might be right for
COVID 19 Associated Coagulopathy
Ain Shams University 46
Not applicableUnknownNCT05330832
What this trial is testing

Covid-19 Associated Coagulopathy Predicted by Thrombodynamic Markers (CoViTro-I)

Who this might be right for
Coronavirus Disease 2019
Federal Research Institute of Pediatric Hematology, Oncology and Immunology 2,200
Not applicableUnknownNCT04405232
What this trial is testing

Coagulopathy in COVID19 - A Multi-Centre Observational Study in UK

Who this might be right for
COVIDThrombosisBleeding+1 more
Imperial College London 5,000
Very early researchStudy completedNCT04419610
What this trial is testing

RAS and Coagulopathy in COVID19

Who this might be right for
COVID
Imperial College London 28
Not applicableUnknownNCT04613986
What this trial is testing

Therapeutic Plasma Exchange as an Adjunctive Strategy to Treat Coagulopathy and Inflammation in Severe Covid-19

Who this might be right for
Severe Covid-19
University of Zurich 20
Not applicableUnknownNCT05534074
What this trial is testing

University Hospital of Ioannina COVID-19 (Coronavirus Disease 2019) Registry

Who this might be right for
COVID-19 (Coronavirus Disease 2019)COVID-19 PandemicCOVID-19 Pneumonia+5 more
University Hospital, Ioannina 2,500
Not applicableStudy completedNCT05496816
What this trial is testing

Coagulation Disturbances in COVID-19 Septic Patients

Who this might be right for
Coagulation DisorderCOVID 19 Associated CoagulopathySepsis+1 more
Cantonal Hospital Zenica 100
Early research (Phase 1)Looking for participantsNCT06355258
What this trial is testing

The Efficacy of Troxerutin in Preventing Thrombotic Events in COVID-19 Patients

Who this might be right for
COVID 19 Associated Coagulopathy
Westlake University 80
Not applicableUnknownNCT06097403
What this trial is testing

Cardiovascular Complications in Children With COVID 19

Who this might be right for
COVID 19 Associated Coagulopathy
Assiut University 100
Not applicableStudy completedNCT04507230
What this trial is testing

COVID-19 Associated Coagulopathy in Egypt

Who this might be right for
Coagulopathy
Assiut University 106
Not applicableNot Yet RecruitingNCT06992401
What this trial is testing

Observational Study of Intranasal IVIG in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Patients Undergoing Medical Tourism

Who this might be right for
Post-Acute Sequelae of SARS-CoV-2 InfectionLong COVIDLong COVID Fatigue+3 more
Tamara C Tamas 50
Not applicableStudy completedNCT04401436
What this trial is testing

COVID-19 Associated Lymphopenia Pathogenesis Study in Blood

Who this might be right for
Coronavirus Disease 2019
National Institute of Allergy and Infectious Diseases (NIAID) 240
Not applicableStudy completedNCT04460664
What this trial is testing

Coagulation Changes Associated With COVID-19 Infection

Who this might be right for
COVIDDisseminated Intravascular CoagulationCoagulation Disorder
HemoSonics LLC 15
Testing effectiveness (Phase 2)WithdrawnNCT04435015
What this trial is testing

The Utility of Camostat Mesylate in Patients With COVID-19 Associated Coagulopathy (CAC) and Cardiovascular Complications

Who this might be right for
CoagulopathyCardiovascular ComplicationCOVID-19
Yale University
Post-approval studies (Phase 4)Study completedNCT04360824
What this trial is testing

Covid-19 Associated Coagulopathy

Who this might be right for
COVID 19 Associated Coagulopathy
University of Iowa 176